Direct antiviral agents against hepatitis C virus: Beneficial or harmful?
J Hepatol
.
2018 Apr;68(4):844-845.
doi: 10.1016/j.jhep.2017.10.026.
Epub 2017 Nov 1.
Authors
Óscar Murcia
1
,
Fernando Carnicer
2
,
Laura Gómez-Escolar
3
,
Cayetano Miralles
4
,
María Pilar Griñó
5
,
Claudia Barquero Martín
6
,
Sonia Pascual
2
Affiliations
1
Department of Hepatology, Hospital General Universitario de Alicante, Spain. Electronic address: omp_89@hotmail.com.
2
Department of Hepatology, Hospital General Universitario de Alicante, Spain.
3
Department of Hepatology, Hospital Marina Baixa, Villajoyosa, Spain.
4
Department of Hepatology, Hospital Vinalopó, Elche, Spain.
5
Department of Hepatology, Hospital San Juan de Alicante, Spain.
6
Department of Hepatology, Hospital General de Torrevieja, Spain.
PMID:
29100994
DOI:
10.1016/j.jhep.2017.10.026
No abstract available
Keywords:
Direct antiviral agent; Hepatitis C virus; Hepatocellular carcinoma; Treatment.
Publication types
Letter
Comment
MeSH terms
Antiviral Agents*
Carcinoma, Hepatocellular*
Hepacivirus
Hepatitis C*
Humans
Liver Neoplasms*
Neoplasm Recurrence, Local
Substances
Antiviral Agents